Pathophysiology of Escherichia coli ventilator-associated pneumonia: Implication of highly virulent extraintestinal pathogenic strains

Intensive Care Medicine

Volumn 38, Issue 12, 2012, Pages 2007-2016

  Messika, Jonathan ^a,b,c   Magdoud, Fatma ^c   Clermont, Olivier ^a,b   Margetis, Dimitri ^a,b,c   Gaudry, Stéphane ^a,b,c   Roux, Damien ^a,b,c   Branger, Catherine ^a,b,c   Dreyfuss, Didier ^a,b,c   Denamur, Erick ^a,b   Ricard, Jean Damien ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

Animal model; Antibiotic resistance; Escherichia coli; Nosocomial infection; Ventilator associated pneumonia; Virulence factor genes

Indexed keywords

CEPHALOSPORIN; PIPERACILLIN PLUS TAZOBACTAM; VIRULENCE FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ESCHERICHIA COLI PNEUMONIA; FEMALE; GENOTYPE; HUMAN; INTENSIVE CARE; IRON GENE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHYLOGENY; PROSPECTIVE STUDY; SFA GENE; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; ANIMALS; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MOLECULAR TYPING; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; VIRULENCE FACTORS;

EID: 84872072606     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2699-5     Document Type: Article

References (51)

1. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329
2. Anonymous (2005) Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416
3. Ricard JD, Conti G, Boucherie M, Hormann C, Poelaert J, Quintel M, Rubertsson S, Torres A (2012) A European survey of nosocomial infection control and hospital-acquired pneumonia prevention practices. J Infect 65(4):285-291
4. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, Merrer J, Herman B, Veber B, Fontaine A, Dreyfuss D, ARDS Study Group (2000) Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. Am J Respir Crit Care Med 161:1942-1948 (Pubitemid 30418134)
5. Dreyfuss D, Ricard JD (2005) Acute lung injury and bacterial infection. Clin Chest Med 26:105-112 (Pubitemid 40410709)
6. Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867-903 (Pubitemid 34774654)
7. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP (1989) Hospitalacquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129:1258-1267 (Pubitemid 19148466)
8. Tenaillon O, Skurnik D, Picard B, Denamur E (2010) The population genetics of commensal Escherichia coli. Nat Rev Microbiol 8:207-217
9. Russo TA, Johnson JR (2000) Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181:1753-1754 (Pubitemid 30387770)
10. Croxen MA, Finlay BB (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8:26-38
11. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602
12. Lynch SV, Wiener-Kronish JP (2008) Novel strategies to combat bacterial virulence. Curr Opin Crit Care 14:593-599
13. Ricard JD (2012) New therapies for pneumonia. Curr Opin Pulm Med 18:181-186
14. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, Frank DW (1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5:392-398 (Pubitemid 29180576)
15. Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T (2002) Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis 186:64-73 (Pubitemid 34666915)
16. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546-553 (Pubitemid 29059185)
17. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrugresistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001 J Infect Dis 190:1739-1744
18. Escobar-Paramo P, Grenet K, Le Menac'h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R (2004) Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol 70:5698-5700 (Pubitemid 39279653)
19. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic groups. Appl Environ Microbiol 66:4555-4558
20. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentre F, Fantin B, Wolff M, Denamur E (2011) Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49:777-783
21. Escobar-Paramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguenec C, Denamur E (2004) A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 21:1085-1094 (Pubitemid 38658217)
22. Branger C, Bruneau B, Lesimple AL, Bouvet PJ, Berry P, Sevali-Garcia J, Lambert-Zechovsky N (1997) Epidemiological typing of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. J Hosp Infect 36:23-36 (Pubitemid 27235033)
23. Clermont O, Johnson JR, Menard M, Denamur E (2007) Determination of Escherichia coli O types by allelespecific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 57:129-136 (Pubitemid 46135872)
24. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O (2007) Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24:2373-2384 (Pubitemid 350060443)
25. Byrd W, Mog SR, Cassels FJ (2003) Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A. Infect Immun 71:13-21 (Pubitemid 36025999)
26. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103:12879-12884 (Pubitemid 44298655)
27. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M (2011) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67:346-356
28. Souweine B, Veber B, Bedos JP, Gachot B, Dombret MC, Regnier B, Wolff M (1998) Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 26:236-244 (Pubitemid 28082683)
29. Peleg AY, Hooper DC (2010) Hospitalacquired infections due to gramnegative bacteria. N Engl J Med 362:1804-1813
30. Russo TA, Davidson BA, Carlino-MacDonald UB, Helinski JD, Priore RL, Knight PR 3rd (2003) The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia. FEMS Microbiol Lett 226:355-361 (Pubitemid 38444962)
31. Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S (2007) Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 75:1916-1925 (Pubitemid 46559461)
32. Wieser A, Romann E, Magistro G, Hoffmann C, Norenberg D, Weinert K, Schubert S (2010) A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect Immun 78:3432-3442
33. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HLT (2009) Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 5:e1000586
34. Hamet M, Pavon A, Dalle F, Pechinot A, Prin S, Quenot JP, Charles PE (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38(8):1272-1279
35. Ricard JD, Roux D (2012) Candida colonization in ventilated ICU patients: no longer a bystander! Intensive Care Med 38(8):1243-1245
36. Russo TA, Wang Z, Davidson BA, Genagon SA, Beanan JM, Olson R, Holm BA, Knight PR 3rd, Chess PR, Notter RH (2007) Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model. Am J Physiol Lung Cell Mol Physiol 292:L632-L643 (Pubitemid 46376981)
37. Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281:1137-1140
38. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD, Johanson WG (1972) Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 77:701-706
39. de Latorre FJ, Pont T, Ferrer A, Rossello J, Palomar M, Planas M (1995) Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med 152:1028-1033
40. Bingen E, Picard B, Brahimi N, Mathy S, Desjardins P, Elion J, Denamur E (1998) Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 177:642-650 (Pubitemid 28099878)
41. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR (2004) Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 190:2121-2128 (Pubitemid 39636359)
42. Meybeck A, Ricard JD, Barnaud G, Eveillard M, Chevrel G, Mounier R, Dreyfuss D (2008) Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study. BMC Infect Dis 8:67
43. Levert M, Zamfir O, Clermont O, Bouvet O, Lespinats S, Hipeaux M, Branger C, Picard B, Saint-Ruf C, Norel F, Balliau T, Zivy M, Le Nagard H, Cruvellier S, Chane-Woo-Ming B, Nilsson S, Gudelj I, Phan K, Ferenci T, Tenaillon O, Denamur E (2010) Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS Pathog 6:e1001125
44. Morand B, Muhlemann K (2007) Heteroresistance to penicillin in Streptococcus pneumoniae. Proc Natl Acad Sci USA 104:14098-14103 (Pubitemid 350003341)
45. Rinder H, Mieskes KT, Loscher T (2001) Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 5:339-345 (Pubitemid 32397584)
46. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L (2006) Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50:2946-2950 (Pubitemid 44396396)
47. Yamazumi T, Pfaller MA, Messer SA, Houston AK, Boyken L, Hollis RJ, Furuta I, Jones RN (2003) Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol 41:267-272 (Pubitemid 36098586)
48. Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE (2003) The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71:7164-7169 (Pubitemid 37475350)
49. Tourret J, Diard M, Garry L, Matic I, Denamur E (2010) Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence. Int J Med Microbiol 300:435-439
50. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963 (Pubitemid 24000804)
51. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, Barraud D, Bingen E (2002) Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 70:3216-3226 (Pubitemid 34564186)